Efferent Labs’ Living Biosensor Could Save Pharma, Device Firms Money
Efferent Labs’ Living Biosensor Could Save Pharma, Device Firms Money
Efferent Labs’ Living Biosensor Could Save Pharma, Device Firms Money
Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology.
https://youtu.be/hdfwZ0FUpXA
A new device created at the University of Rochester could provide physicians with real time information about the health of their patients.
Raland’s CytoComm™ technology has been issued another patent.
Raland Therapeutics featured in Democrat & Chronicle headline news article.
Raland Therapeutics is a finalist in the $5M 43North competition.
Raland Therapeutics is one of the eleven finalists in a worldwide business competition
Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition.